Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) – 2023 to 2028

SKU: GMS-2096

Format: PDF

Overall Rating
☆☆☆☆☆ 4.5/5

OVERVIEW

The global market for human liver models is expected to hit USD 4.23 billion by 2025, rising over the forecast period at a CAGR of 11.91%. The growth of this market is driven primarily by factors such as the rising emphasis on developing alternatives for animal testing models, a substantial increase in research funding and investment in venture capital for the production of liver models, the initiatives to raise awareness of liver organoids, raising the prevalence of non-alcoholic fatty liver disease and raising ear need

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 1

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 2

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 3

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 4

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 5

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 6

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 7

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 8

TABLE OF CONTENT

1 Global Human Liver Models Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Human Liver Models Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Human Liver Models Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Human Liver Models Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Human Liver Models Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Human Liver Models Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Human Liver Models Market – By Drug Discovery Platform (Market Size – &
million/billion)
8.1 Liver Organoids
8.2 Liver-on-a-chip
8.3 2D Models
8.4 Animal Models
8.5 3D Bioprinting

9 Global Human Liver Models Market – By Geography (Market Size – & million/billion)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 U.K
9.3.2 Germany
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Rest of APAC
9.5 Rest of the World
9.5.1 South America
9.5.2 Middle East
9.5.3 Africa

10 Global Human Liver Models Market – Entropy
10.1 New product launches
10.2 M&A’s, collaborations, JVs and partnerships

11 Global Human Liver Models Market Company Profile (Key Players)
11.1 Market Share, Company Revenue, Products, M&A, Developments
11.2 Emulate
11.3 Ascendance Bio
11.4 HìREL
11.5 CN Bio
11.6 Organovo
11.7 Cyfuse Biomedical
11.8 Company 7
11.9 Company 8
11.10 Company 9
11.11 Company 10
11.12 Company 11 & more

12 Global Human Liver Models Market – Appendix
12.1 Sources
12.2 Abbreviations

Share

Get A Free Sample

Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.

Send me Free Sample

Or View Our License Options:

$3,850.00 – $5,850.00

Why

Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.

Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.

We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.

We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.

At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.

83422+ Reports Delivered

Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.

Need Customized Report ?Call Now

OVERVIEW

The global market for human liver models is expected to hit USD 4.23 billion by 2025, rising over the forecast period at a CAGR of 11.91%. The growth of this market is driven primarily by factors such as the rising emphasis on developing alternatives for animal testing models, a substantial increase in research funding and investment in venture capital for the production of liver models, the initiatives to raise awareness of liver organoids, raising the prevalence of non-alcoholic fatty liver disease and raising ear need

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 9

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 10

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 11

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 12

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 13

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 14

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 15

Human liver models market by drug discovery platform (liver-on-a-chip, non-alcoholic fatty liver organoids, 2d models, animal models, 3d bioprinting), and region (north america, europe, asia pacific, rest of the world) - 2023 to 2028 16

TABLE OF CONTENT

1 Global Human Liver Models Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Human Liver Models Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Human Liver Models Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Human Liver Models Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Human Liver Models Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Human Liver Models Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Human Liver Models Market – By Drug Discovery Platform (Market Size – &
million/billion)
8.1 Liver Organoids
8.2 Liver-on-a-chip
8.3 2D Models
8.4 Animal Models
8.5 3D Bioprinting

9 Global Human Liver Models Market – By Geography (Market Size – & million/billion)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 U.K
9.3.2 Germany
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Rest of APAC
9.5 Rest of the World
9.5.1 South America
9.5.2 Middle East
9.5.3 Africa

10 Global Human Liver Models Market – Entropy
10.1 New product launches
10.2 M&A’s, collaborations, JVs and partnerships

11 Global Human Liver Models Market Company Profile (Key Players)
11.1 Market Share, Company Revenue, Products, M&A, Developments
11.2 Emulate
11.3 Ascendance Bio
11.4 HìREL
11.5 CN Bio
11.6 Organovo
11.7 Cyfuse Biomedical
11.8 Company 7
11.9 Company 8
11.10 Company 9
11.11 Company 10
11.12 Company 11 & more

12 Global Human Liver Models Market – Appendix
12.1 Sources
12.2 Abbreviations

Related Research Reports

Related products